References
Opie LH, Bruyneel K, Owen P: Effects of glucose, insulin, potassium infusion and tissue metabolic changes within first hour of myocardial infarction in the baboon. Circulation 1975, 52:49–57.
Apstein CS, Gravino FN, Haudenschild CC: Determinants of a protective effect of glucose and insulin on the ischemic myocardium: effects on contractile function, diastolic compliance, metabolism, and ultrastructure during ischemia and reperfusion. Circ Res 1983, 52:515–526.
Jonassen AK, Sack MN, Mjos OD, Yellon DM: Myocardial protection by insulin at reperfusion requires early administration and is mediated via Akt and p70s6 kinase cell-survival signaling. Circ Res 2001, 89:1191–1198.
Taegtmeyer H: Energy metabolism of the heart: from basic concepts to clinical applications. Curr Prob Cardiol 1994, 19:57–116.
Goodwin GW, Taylor CS, Taegtmeyer H: Regulation of energy metabolism of the heart during acute increase in heart work. J Biol Chem 1998, 273:29530–29539.
Korvald C, Elvenes OP, Myrmel T: Myocardial substrate metabolism influences left ventricular energetics in vivo. Am J Physiol Heart Circ Physiol 2000, 278:H1345-H1351.
Gradinac S, Coleman G, Taegtmeyer H, et al.: Improved cardiac function with glucose-insulin-potassium after aortocoronary bypass grafting. Ann Thorac Surg 1989, 48:484–489.
Califf R: Simple principles of clinical trials remain powerful. JAMA 2005, 293:489–491.
De Luca G, Suryapranata H, Stone G, et al.: Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials. JAMA 2005, 293:1759–1765.
Apstein C, Opie L: A challenge to the metabolic approach to myocardial ischaemia. Eur Heart J 2005, 26:956–959.
Rights and permissions
About this article
Cite this article
Taegtmeyer, H. Clinical trials report. Current Science Inc 7, 397–398 (2005). https://doi.org/10.1007/s11906-005-0031-2
Issue Date:
DOI: https://doi.org/10.1007/s11906-005-0031-2